Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?-Reference-Cited by-同舟云学术

Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?

Published:2016-06 Issue:6 Volume:195 Page:1754-1759
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Toussi Amir¹,Stewart-Merrill Suzanne B.¹,Boorjian Stephen A.¹,Psutka Sarah P.¹,Thompson R. Houston¹,Frank Igor¹,Tollefson Matthew K.¹,Gettman Matthew T.¹,Carlson Rachel E.²,Rangel Laureano J.²,Karnes R. Jeffrey¹

Affiliation:

1. Department of Urology, Mayo Clinic, Rochester, Minnesota

2. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

2. Cancer control with radical prostatectomy alone in 1,000 consecutive patients;Hull;J Urol,2002

3. Biological determinants of cancer progression in men with prostate cancer;Stamey;JAMA,1999

4. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence;Boorjian;Eur Urol,2011

5. Nomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomy;Brockman;Eur Urol,2015

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive multi-omics analysis reveals the molecular mechanism of prostate cancer recurrence;2024-08-22

2. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

3. An Analysis of the Diagnostic Performance of Tc-99m PSMA SSPECT/CT in Biochemically Recurrent Prostate Cancer Compared with Ga-68 PSMA PET/CT: A Single-center, Prospective Study;Indian Journal of Nuclear Medicine;2024-05

4. DNA Ploidy as a Potential Adjunct Prognostic Marker of Low-Risk Prostate Cancer Progression after Radical Prostatectomy;UROL J;2024

5. Controversies in Management of Localized Prostate Cancer: Before and After Radical Local Therapy;UroCancer Clinics of India;2024-01